Abstract:Autism spectrum disorder (ASD) is a complex neurological developmental disorder in children, and is associated with social isolation and restricted interests. The etiology of this disorder is still unknown. There is neither any confirmed laboratory test nor any effective therapeutic strategy to diagnose or cure it. We performed data independent acquisition (DIA) and multiple reaction monitoring (MRM) analysis of plasma from children with ASD and controls. The result showed that 45 differentially expressed proteins (DEPs) were identified between autistic subjects and controls. Among these, only one DEP was down-regulated in ASD; other DEPs were up-regulated in ASD children's plasma. These proteins are found associated with complement and coagulation cascades, vitamin digestion and absorption, cholesterol metabolism, platelet degranulation, selenium micronutrient network, extracellular matrix organization and inflammatory pathway, which have been reported to be related to ASD. After MRM verification, five key proteins in complement pathway (PLG, SERPINC1, and A2M) and inflammatory pathway (CD5L, ATRN, SERPINC1, and A2M) were confirmed to be significantly up-regulated in ASD group. Through the screening of machine learning model and MRM verification, we found that two proteins (biotinidase and carbonic anhydrase 1) can be used as early diagnostic markers of ASD (AUC = 0.8, p = 0.0001). Significance: ASD is the fastest growing neurodevelopmental disorder in the world and has become a major public health problem worldwide. Its prevalence has been steadily increasing, with a global prevalence rate of 1%. Early diagnosis and intervention can achieve better prognosis. In this study, data independent acquisition (DIA) and multiple reaction monitoring (MRM) analysis was applied to analyze the plasma proteome of ASD patients (31 (+/- 5) months old), and 378 proteins were quantified. 45 differentially expressed proteins (DEPs) were identified between the ASD group and the control group. They mainly were associated with platelet degranulation, ECM proteoglycar, complement and coagulation cascades, selenium micronutrient network, regulation of insulin-like growth factor (IGF) transport and uptake by insulin-like growth factor binding proteins (IGFBPs), cholesterol metabolism, vitamin metabolism, and inflammatory pathway. Through the integrated machine learning methods and the MRM verification of independent samples, it is considered that biotinidase and carbon anhydrase 1 have the potential to become biomarkers for the early diagnosis of ASD. These results complement proteomics database of the ASD patients, broaden our understanding of ASD, and provide a panel of biomarkers for the early diagnosis of ASD.

Biomarkers for Early Diagnosis of Autism Obtained Through Bioinformatics Analysis of Human Blood Samples

Artificial intelligence and bioinformatics analyze markers of children's transcriptional genome to predict autism spectrum disorder

Diagnostic Classification and Prognostic Prediction Using Common Genetic Variants in Autism Spectrum Disorder: Genotype-Based Deep Learning

The Use of Data Independent Acquisition Based Proteomic Analysis and Machine Learning to Reveal Potential Biomarkers for Autism Spectrum Disorder.

Biomarkers and pathways in autism spectrum disorder: An individual meta-analysis based on proteomic and metabolomic data

Prenatal Exposure of Diabetes and Progestin‐Mediated Autistic Biomarker in Peripheral Blood Mononuclear Cells

Unraveling the immunogenetic landscape of autism spectrum disorder: a comprehensive bioinformatics approach

Unraveling pathogenesis and potential biomarkers for autism spectrum disorder associated with HIF1A pathway based on machine learning and experiment validation

Potential of gut microbiome for detection of autism spectrum disorder

Seeing beyond words: Visualizing autism spectrum disorder biomarker insights

Peptidome Analysis Reveals Novel Serum Biomarkers for Children with Autism Spectrum Disorder in China.

An Integrated Transcriptomic Analysis of Autism Spectrum Disorder

Exploiting Aberrant Mrna Expression in Autism for Gene Discovery and Diagnosis

Expression and Regulatory Network Analysis of miR-140-3p, a New Potential Serum Biomarker for Autism Spectrum Disorder

Proteomics Study of Peripheral Blood Mononuclear Cells (PBMCs) in Autistic Children

Identification of Amino Acid Dysregulation as a Potential Biomarker for Autism Spectrum Disorder in China

Genome-wide DNA methylation profiles of autism spectrum disorder

Investigation of Gene Regulatory Networks Associated with Autism Spectrum Disorder Based on MiRNA Expression in China

The relative usefulness of the identification and analysis of biomarkers for the diagnosis of autism spectrum disorders in early childhood and the implementation of personalized precision medicine

A Combined Proteomics and Metabolomics Profiling to Investigate the Genetic Heterogeneity of Autistic Children

Identification of Immune Infiltration and Iron Metabolism–Related Subgroups in Autism Spectrum Disorder